BE801588A - Nouveaux sels d'alpha-sulfobenzylpenicilline - Google Patents

Nouveaux sels d'alpha-sulfobenzylpenicilline

Info

Publication number
BE801588A
BE801588A BE132836A BE132836A BE801588A BE 801588 A BE801588 A BE 801588A BE 132836 A BE132836 A BE 132836A BE 132836 A BE132836 A BE 132836A BE 801588 A BE801588 A BE 801588A
Authority
BE
Belgium
Prior art keywords
sulfobenzylpenicillin
alpha
new salts
salts
new
Prior art date
Application number
BE132836A
Other languages
English (en)
French (fr)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of BE801588A publication Critical patent/BE801588A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE132836A 1972-07-01 1973-06-28 Nouveaux sels d'alpha-sulfobenzylpenicilline BE801588A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (cg-RX-API-DMAC7.html) 1972-07-01 1972-07-01

Publications (1)

Publication Number Publication Date
BE801588A true BE801588A (fr) 1973-12-28

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
BE132836A BE801588A (fr) 1972-07-01 1973-06-28 Nouveaux sels d'alpha-sulfobenzylpenicilline

Country Status (15)

Country Link
US (1) US3925357A (cg-RX-API-DMAC7.html)
JP (1) JPS5512435B2 (cg-RX-API-DMAC7.html)
AT (1) AT325206B (cg-RX-API-DMAC7.html)
AU (1) AU469986B2 (cg-RX-API-DMAC7.html)
BE (1) BE801588A (cg-RX-API-DMAC7.html)
CA (1) CA996548A (cg-RX-API-DMAC7.html)
CH (1) CH573435A5 (cg-RX-API-DMAC7.html)
CS (1) CS168036B2 (cg-RX-API-DMAC7.html)
DE (1) DE2332840A1 (cg-RX-API-DMAC7.html)
FR (1) FR2190414B1 (cg-RX-API-DMAC7.html)
GB (1) GB1386566A (cg-RX-API-DMAC7.html)
HU (1) HU166029B (cg-RX-API-DMAC7.html)
NL (1) NL7308048A (cg-RX-API-DMAC7.html)
PL (1) PL92969B1 (cg-RX-API-DMAC7.html)
SE (1) SE402916B (cg-RX-API-DMAC7.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (cg-RX-API-DMAC7.html) * 1978-07-29 1980-02-13
DK1757606T3 (da) * 2001-02-24 2009-09-07 Boehringer Ingelheim Pharma Anvendelse af xanthinderivater som l gemidler samt fremgangsm de til deres fremstilling
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20080251A1 (es) * 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
JP5323684B2 (ja) * 2006-05-04 2013-10-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 多形体
AU2008290582B2 (en) * 2007-08-17 2014-08-14 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
EP2326326B1 (en) * 2008-08-15 2019-10-09 Boehringer Ingelheim International GmbH Dpp-4 inhibitors for use for the treatment of wound healing in diabetic patients
JP2012502081A (ja) 2008-09-10 2012-01-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病及び関連症状の治療のための組み合わせ治療
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
TWI508965B (zh) 2008-12-23 2015-11-21 Boehringer Ingelheim Int 有機化合物的鹽形式
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
KR20190071840A (ko) 2009-11-27 2019-06-24 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
MX366325B (es) 2010-05-05 2019-07-05 Boehringer Ingelheim Int Terapia de combinacion.
CA2803504C (en) 2010-06-24 2022-08-30 Boehringer Ingelheim International Gmbh A combination for diabetes therapy comprising linagliptin and a long-acting insulin
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
KR101985384B1 (ko) 2011-07-15 2019-06-03 베링거 인겔하임 인터내셔날 게엠베하 치환된 퀴나졸린, 이의 제조 및 약제학적 조성물에서의 이의 용도
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
JP6218811B2 (ja) 2012-05-14 2017-10-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Sirs及び/又は敗血症の治療に用いるdpp−4阻害薬としてのキサンチン誘導体
EP2849755A1 (en) 2012-05-14 2015-03-25 Boehringer Ingelheim International GmbH A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
BR112018072401A2 (pt) 2016-06-10 2019-02-19 Boehringer Ingelheim International Gmbh combinações de linagliptina e metformina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (cg-RX-API-DMAC7.html) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
JPS4925121A (cg-RX-API-DMAC7.html) 1974-03-06
DE2332840A1 (de) 1974-01-17
FR2190414B1 (cg-RX-API-DMAC7.html) 1976-07-02
CH573435A5 (cg-RX-API-DMAC7.html) 1976-03-15
CS168036B2 (cg-RX-API-DMAC7.html) 1976-05-28
FR2190414A1 (cg-RX-API-DMAC7.html) 1974-02-01
AU5760073A (en) 1975-01-09
JPS5512435B2 (cg-RX-API-DMAC7.html) 1980-04-02
PL92969B1 (cg-RX-API-DMAC7.html) 1977-04-30
CA996548A (en) 1976-09-07
SE402916B (sv) 1978-07-24
AU469986B2 (en) 1976-02-26
AT325206B (de) 1975-10-10
GB1386566A (en) 1975-03-12
NL7308048A (cg-RX-API-DMAC7.html) 1974-01-03
US3925357A (en) 1975-12-09
HU166029B (cg-RX-API-DMAC7.html) 1974-12-28

Similar Documents

Publication Publication Date Title
BE801588A (fr) Nouveaux sels d'alpha-sulfobenzylpenicilline
IT995086B (it) Monoacetali di 1 2 dichetoni aromatici
BE803001A (fr) Generateur d'ultra-sons
BE793601A (fr) Generateur d'ultrasons
BE785478A (fr) Nouveaux cyclopropane-carboxylates d'alcadienyle
BE748699A (fr) Nouveaux sels d'ammonium quaternaire polyfluores
BE796359A (fr) Composition d'oeuf synthetique
BE799586A (fr) Sels de l'acide 3-hydroxyi2-hydroxymethylpropane-sulfonique-1
BE798485A (fr) Production d'esters
BE796216A (fr) Nouveaux sels de metaux d'acides dithiocarbamiques
IT1045864B (it) Accouplement d'ambre
IT1004018B (it) Preparazione di poliammidi
IT987593B (it) Solfoni con concatenazione di dineti o 1 6 esadien 1 5 ilene
BR7306933D0 (pt) Tesourao
BE788335A (fr) Nouveaux sels d'ammonium quaternaires polyfluores
BE802272A (fr) Nouveaux sels de vincanol
BE780630A (fr) Nouveaux derives d'imidazo-pyridine
BE770581A (fr) Nouveaux sels de cephalexine
BE798531A (fr) Derives o-substitues d'oximes
BE795474A (fr) Sels alcalins d'acides polyester-carboxyliques, et leur preparation
BE808591A (fr) Derives d'acide amidomethane-phosphonique
FR2324632A1 (fr) Nicotinamide-n-ethyl-thionicotinate et ses sels
BE796447A (fr) Nouveaux esterimides d'acides n-(aminomethylidene)-thiol-phosphoriques
BE795041A (fr) Nouveaux derives de l'amino-propane
BE808147A (fr) Nouveaux derives de 2'-fluorobiphenyles